The connection
Obstructive sleep apnoea (OSA) is strongly linked to obesity — excess weight around the neck and airway contributes to airway collapse during sleep. Weight loss of 5–10% can significantly improve OSA severity, and in some cases, resolve it entirely.
Sleep apnoea as eligibility criteria
OSA qualifies as a weight-related comorbidity under TGA guidelines. This means you may be eligible for weight loss medication at a BMI of 27 or above (rather than the standard 30 threshold) if you have diagnosed sleep apnoea.
Which medications help?
GLP-1 medications like Wegovy and Mounjaro are particularly effective for the amount of weight loss needed to improve OSA. The STEP trials showed significant improvements in sleep apnoea severity scores alongside weight loss.
What to tell your doctor
If you have diagnosed or suspected sleep apnoea, mention this to your prescribing doctor. It may affect your eligibility (positively) and can influence medication choice.